News
After nearly 27 years as a division of Swiss giant Novartis, generics and biosimilars specialist Sandoz (SWX: SDZ) went its ...
The US Food and Drug Administration (FDA) approved San Diego, USA-based LENZ Therapeutics’ VIZZ (aceclidine ophthalmic ...
England has agreed to commission the use of Hemlibra (emicizumab) as a prophylactic treatment for patients of all ages with ...
German healthcare and crop sciences giant Bayer (BAYN DE) saw its share close up 2.8% at 28.12 euros, after it provided an ...
Swiss pharma giant Roche announced positive five-year efficacy, safety and durability data from the Phase III Portal study, a ...
US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals (Nasdaq: ARWR) today announced that its majority-owned subsidiary Visirna Therapeutics has signed an asset purchase agreement with France ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results